Nu-Med Plus Amends Bylaws to Require Shareholder Approval for Domicile Change From Utah

• Nu-Med Plus’ board amended its bylaws on November 2, 2026, effective the same day, to clarify shareholder approval requirements.
• Any transfer of domicile or domestication outside Utah requires a majority of votes cast by shares entitled to vote.
• The vote must occur at a meeting with a quorum present, with shares represented in person or by proxy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nu-Med Plus Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001575872-26-000755), on November 02, 2026, and is solely responsible for the information contained therein.